Validation of a biological score to predict response in chronic lymphocytic leukemia patients treated front-line with bendamustine and rituximab

被引:0
|
作者
Massimo Gentile
Tait D. Shanafelt
Gianluigi Reda
Francesca Romana Mauro
Katja Zirlik
Stefania Ciolli
Luca Laurenti
Maria Ilaria Del Principe
Davide Rossi
Nicola Di Renzo
Stefano Molica
Francesco Angrilli
Marta Coscia
Annalisa Chiarenza
Annamaria Giordano
Giovanna Cutrona
Kari G. Chaffee
Sameer A. Parikh
Giuseppina Uccello
Idanna Innocenti
Giovanni Tripepi
Graziella D’Arrigo
Ernesto Vigna
Anna Grazia Recchia
Yair Herishanu
Lev Shvidel
Tamar Tadmor
Agostino Cortelezzi
Giovanni Del Poeta
Gianluca Gaidano
Francesco Di Raimondo
Antonino Neri
Manlio Ferrarini
Robin Foà
Aaron Polliack
Fortunato Morabito
机构
[1] A.O. of Cosenza,Hematology Unit, Department of Onco
[2] Stanford University,Hematology
[3] Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico and University of Milan,Department of Medicine, Division of Hematology
[4] ‘Sapienza’ University,Hematology Unit
[5] University Medical Centre Freiburg,Hematology, Department of Cellular Biotechnologies and Hematology
[6] University of Florence,Department of Haematology and Oncology
[7] Catholic University Hospital “A. Gemelli”,Department of Hematology
[8] Università degli studi di Roma “Tor Vergata”,Ematologia, Dipartimento di Biomedicina e Prevenzione
[9] Oncology Institute of Southern Switzerland and Institute of Oncology Research,Unità di Ematologia
[10] Ospedale Vito Fazzi,Department of Oncology and Haematology
[11] Pugliese-Ciaccio Hospital,Department of Hematology
[12] Ospedale Santo Spirito,Division of Haematology, University of Torino
[13] A.O. Città della Salute e della Scienza di Torino,Department of Biomedical Sciences, Division of Haematology
[14] University of Catania and Ferrarotto Hospital,Ematologia
[15] Policlinico Consorziale di Bari,Azienda Ospedaliero
[16] Ospedale Policlinico San Martino IRCCS,Universitaria
[17] Mayo Clinic,UO Molecular Pathology
[18] Mayo Clinic,Division of Biomedical Statistics and Informatics
[19] Instituto di Biomedicina ed Immunologia Molecolare,Department of Internal Medicine, Division of Hematology
[20] Azienda Sanitaria Provinciale di Cosenza,Consiglio Nazionale delle Ricerche
[21] Tel Aviv Sourasky Medical Center,Biotechnology Research Unit
[22] Kaplan Medical Center,Department of Hematology
[23] Bnai-Zion Medical Center,Hematology Institute
[24] Università del Piemonte Orientale,Hematology Unit
[25] Direzione Scientifica Ospedale Policlinico San Martino IRCCS,Division of Haematology, Department of Translational Medicine
[26] Hospital and Hebrew University Medical School,Department of Hematology, Hadassah University
来源
Leukemia | 2018年 / 32卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1869 / 1873
页数:4
相关论文
共 50 条
  • [1] Validation of a biological score to predict response in chronic lymphocytic leukemia patients treated front-line with bendamustine and rituximab
    Gentile, Massimo
    Shanafelt, Tait D.
    Reda, Gianluigi
    Mauro, Francesca Romana
    Zirlik, Katja
    Ciolli, Stefania
    Laurenti, Luca
    Del Principe, Maria Ilaria
    Rossi, Davide
    Di Renzo, Nicola
    Molica, Stefano
    Angrilli, Francesco
    Coscia, Marta
    Chiarenza, Annalisa
    Giordano, Annamaria
    Cutrona, Giovanna
    Chaffee, Kari G.
    Parikh, Sameer A.
    Uccello, Giuseppina
    Innocenti, Idanna
    Tripepi, Giovanni
    D'Arrigo, Graziella
    Vigna, Ernesto
    Recchia, Anna Grazia
    Herishanu, Yair
    Shvidel, Lev
    Tadmor, Tamar
    Cortelezzi, Agostino
    Del Poeta, Giovanni
    Gaidano, Gianluca
    Di Raimondo, Francesco
    Neri, Antonino
    Ferrarini, Manlio
    Foa, Robin
    Polliack, Aaron
    Morabito, Fortunato
    LEUKEMIA, 2018, 32 (08) : 1869 - 1873
  • [2] Front-Line Therapy for Chronic Lymphocytic Leukemia
    Desai, Sheetal
    Pinilla-Ibarz, Javier
    CANCER CONTROL, 2012, 19 (01) : 26 - 36
  • [3] Standard Duration of Varicella Zoster Virus Prophylaxis May be Inadequate to Prevent Viral Reactivation in Patients with Chronic Lymphocytic Leukemia Treated with Front-Line Bendamustine Plus Rituximab
    Allen, Joshua M.
    Rybicki, Lisa A.
    Caimi, Paolo F.
    Jagadeesh, Deepa
    Dean, Robert M.
    Pohlman, Brad
    Smith, Mitchell R.
    Kalaycio, Matt
    Hill, Brian T.
    BLOOD, 2015, 126 (23)
  • [4] FRONT-LINE THERAPY WITH CHLORAMBUCIL PLUS RITUXIMAB IN ELDERLY AND/OR UNFIT PATIENTS AFFECTED BY CHRONIC LYMPHOCYTIC LEUKEMIA
    Innocenti, I.
    Tarnani, M.
    Vannata, B.
    De Padua, L.
    Santini, F.
    Marietti, S.
    Za, T.
    Bellesi, S.
    Autore, F.
    Chiusolo, P.
    Sora, F.
    Sica, S.
    Leone, G.
    Laurenti, L.
    HAEMATOLOGICA, 2012, 97 : 523 - 524
  • [5] Front-line chronic lymphocytic leukemia: The role of chemoimmunotherapy
    Kim, Myung Sun
    Prasad, Vinay
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (04) : 560 - 561
  • [6] Controversies in the front-line management of chronic lymphocytic leukemia
    Nabhan, Chadi
    Shanafelt, Tait D.
    Kay, Neil E.
    LEUKEMIA RESEARCH, 2008, 32 (05) : 679 - 688
  • [7] Front-Line Therapy for Elderly Chronic Lymphocytic Leukemia Patients: Bendamustine Plus Rituximab or Chlorambucil Plus Rituximab? Real-Life Retrospective Multicenter Study in the Lazio Region
    Autore, Francesco
    Innocenti, Idanna
    Corrente, Francesco
    Del Principe, Maria Ilaria
    Rosati, Serena
    Falcucci, Paolo
    Fresa, Alberto
    Conte, Esmeralda
    Limongiello, Maria Assunta
    Renzi, Daniela
    De Padua, Laura
    Andriani, Alessandro
    Pisani, Francesco
    Cimino, Giuseppe
    Tafuri, Agostino
    Montanaro, Marco
    Mauro, Francesca Romana
    Del Poeta, Giovanni
    Laurenti, Luca
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [8] FRONT-LINE THERAPY FOR ELDERLY CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: BENDAMUSTINE PLUS RITUXIMAB OR CHLORAMBUCIL PLUS RITUXIMAB? REAL-LIFE RETROSPECTIVE MULTICENTER STUDY IN THE LAZIO REGION.
    Autore, F.
    Innocenti, I.
    Corrente, F.
    Del Principe, M. I.
    Rosati, S.
    Falcucci, P.
    Conte, E.
    Limongiello, M. A.
    Renzi, D.
    De Padua, L.
    Andriani, A.
    Pisani, F.
    Cimino, G.
    Tafuri, A.
    Montanaro, M.
    Mauro, F. R.
    Del Poeta, G.
    Laurenti, L.
    HAEMATOLOGICA, 2019, 104 : 103 - 104
  • [9] Oral fludarabine and cyclophosphamide as front-line chemotherapy in patients with chronic lymphocytic leukemia.: The impact of biological parameters in the response duration
    Laurenti, Luca
    Tarnani, Michela
    De Padua, Laura
    Efremov, Dimitar G.
    Zini, Gina
    Garzia, Mariagrazia
    Piccirillo, Nicola
    Chiusolo, Patrizia
    Sora, Federica
    Innocenti, Idanna
    Sica, Simona
    Leone, Giuseppe
    ANNALS OF HEMATOLOGY, 2008, 87 (11) : 891 - 898
  • [10] Oral fludarabine and cyclophosphamide as front-line chemotherapy in patients with chronic lymphocytic leukemia. The impact of biological parameters in the response duration
    Luca Laurenti
    Michela Tarnani
    Laura De Padua
    Dimitar G. Efremov
    Gina Zini
    Mariagrazia Garzia
    Nicola Piccirillo
    Patrizia Chiusolo
    Federica Sorà
    Idanna Innocenti
    Simona Sica
    Giuseppe Leone
    Annals of Hematology, 2008, 87 : 891 - 898